Twitter Beğeni Hilesi

🏆@alvaroquintanal of @mskcancercenter shares his experience at #EGFRSummit! #EGFR #NSCLC #LCSM @egfrresisters

Well, this got interesting… EGFR Resisters EGFRm NSCLC EGFR Resisters Research Summit #LCSM Chat

Dr. Luis E. Raez Narjust Florez, MD, FASCO EGFR Resisters EGFR Resisters Research Summit EGFRm NSCLC EGFR Positive Lung Cancer UK Dana Farber's EGFR-Mutant Lung Cancer Center Thank you, Dr Raez. Given the younger age of so many of us with oncogene-driven lung cancer, pregnancy is a key topic for us.

whos ready for #EGFRsummit 2024

Thanks to GRACE and H. Jack West, MD, FASCO for giving us the opportunity to help our patients and advocates with Narjust Florez, MD, FASCO Stephen V Liu, MD Dr. Estela Rodriguez I.DagogoJackMD Jared Weiss #lungcancer #lcsm EGFR Resisters EGFR Resisters Research Summit ALK Positive NTRKers The ROS1ders, Inc. EGFRm NSCLC EGFR Positive Lung Cancer UK

Are you ready to share your #Research for #EGFRSummit 2024??? #EGFR #NSCLC #LCSM @egfrresisters

The U.S. FDA has granted breakthrough therapy designation to sunvozertinib (DZD9008) from Dizal Pharmaceutical as frontline treatment for patients with metastatic NSCLC whose disease harbors an EGFR exon 20 insertion mutation! more options for our EGFR Resisters patients EGFR Resisters Research Summit

Who’s ready for the next #EGFRSummit?! #EGFR #NSCLC #LCSM @egfrresisters

These are good news for our patients wiht EGFR tumors we need more studies with uncommon mutations and its good to know that osimertinib is an option for them, there is not a lot of experience in compound mutations yet EGFR Resisters EGFR Resisters Research Summit EGFRm NSCLC EGFR Positive Lung Cancer UK #lungcancer

Ivy Elkins began countless essential dialogues supporting lung cancer patients. The lung cancer community has lost a champion, but her work will continue to provide resources and guidance for patients, caregivers, and health care professionals. The team at CE Concepts expresses

I'm hosting the upcoming Fellows Scholar Program with CME Outfitters, Clinical Pathways in T2D Care: Overcoming Inertia, Implementing Innovation in Resemont, IL on 09/14-15/2024. Register today! Early applicants receive travel scholarship: cmeo.me/ec002.   #MedX #MedEd

🎉 Ready to elevate your # LungCancer #Research skills & career? Join us for #EGFRSummit in collab w/@egfrresisters & @CEC_onc Submit your abstracts by Sept 30 & gain valuable career insights ➡ ce.ceconcepts.com/EGFR24 Jill Feldman Zosia Piotrowska #LCSM #EGFR

Wonderful opportunity to interact with the thought leaders of EGFR+ lung cancer. The inaugural meeting in 2019 motivated me to come back to clinic.

Will you be a first-time attendee at #EGFRSummit? Submit Abstracts by September 30 ➡️➡️➡️ ce.ceconcepts.com/EGFR24 @egfrresisters & @CEC_onc Jill Feldman Zosia Piotrowska Stephen V Liu, MD Helena Yu Mary Jo Fidler Christine Lovly, MD, PhD #EGFR #NSCLC #LCSM

🚨 Have you submitted your abstract for #EGFRSummit? ⏳️ Deadline is Sept 30 -📈your career as a #LungCancer researcher! Submit abstracts ➡️ ce.ceconcepts.com/EGFR24 @egfrresisters @CEC_onc Jill Feldman Zosia Piotrowska Stephen V Liu, MD Helena Yu Mary Jo Fidler Christine Lovly, MD, PhD

It's that time! Submit your abstract for the EGFR Resisters Research Summit! Great opportunity to network with thought leaders in #lungcancer, other early career investigators, and of course, a few advocates💪 The deadline to submit abstracts is September 30th. You can submit

🎉 Ready to boost your #LungCancer #Research skills? Join us for the #EGFRSummit in collab w/@egfrresisters & @CEC_onc ⏰Abstracts Deadline - Sept 30 ➡ce.ceconcepts.com/EGFR24 Jill Feldman Zosia Piotrowska Stephen V Liu, MD Helena Yu Mary Jo Fidler Christine Lovly, MD, PhD #LCSM #EGFR

What is your area of interest for this year's #EGFRSummit? Deadline to Submit Abstracts: Sept 30 ➡️➡️ ce.ceconcepts.com/EGFR24 @egfrresisters & @CEC_onc Jill Feldman Zosia Piotrowska Stephen V Liu, MD Helena Yu Mary Jo Fidler Christine Lovly, MD, PhD #EGFR #NSCLC #LCSM

🎯 Calling all #LungCancer researchers! Submit your abstract for #EGFRSummit DEADLINE Sept 30➡ce.ceconcepts.com/EGFR24 Jill Feldman Zosia Piotrowska Stephen V Liu, MD Helena Yu Mary Jo Fidler Christine Lovly, MD, PhD @egfrresisters @CEC_onc #LCSM #EGFR

🌟 Unlock new possibilities in #LungCancer #Research Submit your abstract by Sept 30 ➡ce.ceconcepts.com/EGFR24 Jill Feldman Zosia Piotrowska @egfrresisters Stephen V Liu, MD Helena Yu Mary Jo Fidler Christine Lovly, MD, PhD @CEC_onc #LCSM #EGFR #EGFRSummit